crucial to prevent addiction to tobacco, and to enhance the Benzyl isothiocyanate (BITC) inhibits lung tumorigenesis efficacy of smoking cessation and reduction programs, these induced in A/J mice by benzo [ 
a]pyrene (B[a]P). In contrast,
approaches have had little impact in the 1990s, when overall phenethyl isothiocyanate (PEITC) does not. We tested the smoking prevalence rates in the USA have remained essentially hypothesis that BITC inhibits B[a]P tumorigenicity in mouse constant (1). Chemoprevention is one approach to decreasing lung by inhibiting DNA adduct formation, and compared lung cancer risk in addicted smokers. the effects of BITC and PEITC. In mouse liver or lung
Our goal is to develop chemopreventive agents that are microsomal incubations, BITC and PEITC inhibited formaeffective against lung carcinogens in tobacco smoke (3). ). However, efficacy is highly microsomes from BITC-treated mice, whereas it was subdependent on the structure of the isothiocyanate. Benzyl stantially increased in mice treated with PEITC. Effects isothiocyanate (PhCH 2 NϭCϭS; BITC) inhibits lung tumor on B[a]P metabolism in liver microsomes were generally induction by B[a]P in mice, whereas phenethyl isothiocyanate modest. Conversion of B[a]P-7,8-diol to mutagens by mouse (PhCH 2 CH 2 NϭCϭS; PEITC) is ineffective (7-10). In contrast, liver microsomes was more strongly inhibited by BITC than PEITC is a strong inhibitor of mouse lung tumorigenesis PEITC. Effects on 7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrainduced by NNK, but BITC is ineffective (6).
hydrobenzo[a]pyrene (BPDE)-DNA adduct formation were
Two studies have examined BITC as an inhibitor of B[a]Pevaluated in DNA from mice treated with isothiocyanates induced lung tumorigenesis in A/J mice. Wattenberg adminisand B[a]P, and killed 2-120h later. The area under the tered BITC, at doses of 16.8 or 6.7 µmol, by gavage 15 min curve (AUC) for BPDE-DNA adducts in lung was 29.5% less prior to gavage of B[a]P (7.9 µmol) (7). This sequence was (P ⍧ 0.001) in the BITC-B[a]P treated mice and 19. 0% repeated three times at 2 week intervals. In mice treated with less (P ⍧ 0.02) in the PEITC-B[a]P mice than in the mice B[a]P only, there were 15.5 lung tumors per mouse. This was treated with B[a]P alone. Similar results were obtained in decreased to 7.4 and 3.9 lung tumors per mouse in the animals liver DNA. There were no significant differences between pre-treated with the 6.7 and 16.8 µmol doses of BITC, the reduction of BPDE-DNA AUC values by BITC versus respectively. We used the same protocol and compared the PEITC. The results of this study support the hypothesis that efficacy of BITC and PEITC, each at doses of 7.9 µmol (8).
BITC inhibits B[a]P-induced lung tumorigenesis in A/J mice
In the mice treated with B[a]P only, there were 4.8 lung by inhibiting the metabolic activation of B[a]P to BPDEtumors per mouse. This was significantly reduced to 2.6 lung DNA adducts. However, differences in BPDE-DNA adduct tumors per mouse by BITC, whereas PEITC had no effect. formation do not appear to explain fully the contrasting Two other experiments in A/J mice have examined the effect effects of BITC and PEITC on B[a]P-induced lung of PEITC on B[a]P-induced lung tumorigenesis (9,10). In one, tumorigenesis.
PEITC was administered by gavage before and after a single i. arene oxides can rearrange to phenols or undergo hydration Studies with microsomes isolated from mice pre-treated with BITC or PEITC were carried out the same way. Three pools of lung microsomes were used and each incubation was carried out in duplicate. Three liver microsomal samples were each analyzed in duplicate.
Liver microsomes were used for activation of B[a]P-7,8-diol in the umu assay as described previously (19).
Isolation of DNA from tissues DNA was isolated by modifications of the Kirby method (20). In brief, the tissues were homogenized in 50 mM Tris, 1 mM EDTA pH 7.4, and incubated with 1% sodium dodecyl sulfate and proteinase K (300 µg/ml). The homogenates were extracted twice with phenol/chloroform/isoamyl alcohol (25:24:1) and then once with chloroform/isoamyl alcohol (24:1). DNA was precipitated with ethanol and dissolved in 15 mM sodium citrate, 15 mM sodium chloride, 1 mM EDTA, pH 7.4. The DNA was incubated with RNase A (100 µg/ml) and RNase T1 (2000 U), extracted once with chloroform/ isoamyl alcohol and precipitated with ethanol. Absorbance ratios at 260/230 and 260/280 nm of DNA were 2.31 Ϯ 0.17 (n ϭ 382) and 1.74 Ϯ 0.05 (n ϭ 382), respectively. About 100 µg of each DNA sample were used for fluorometric analysis of B[a]P-tetraols and G.
Hydrolysis of DNA
Prior to hydrolysis, lung or liver DNA samples were analyzed for unbound B[a]P-tetraols. The portion of DNA to be hydrolyzed was rinsed with 100% ethanol, the ethanol was removed and mixed with H 2 O to make a final concentration of 20% ethanol. The ethanol wash was analyzed for B[a]Ptetraols as described below. The DNA, free of unbound B[a]P-tetraols, was dissolved in H 2 O and the DNA concentration was determined by UV to Comparisons between metabolite levels in microsomes from mice treated with illustrated in Figure 2 . We did not find it necessary to purify the HCl prior to vehicle only, BITC or PEITC were made using Student's t-test. Areas under use. The hydrolyzed DNA was stored at -20°C until analyzed by HPLC/ the curve (AUC) were analyzed by analysis of variance. When the overall Ffluorescence. Silanized, amber, high recovery autosampler vials were prepared test was significant, post-hoc t-tests were conducted to determine which of the so that 75 µg DNA would be injected in a 900 µl injection. Internal standard, AUC differed. A P-value of 0.05 or less was considered statistically significant. B[a]P-triol, was added to each vial and the total volume in the autosampler vial was brought to 1.0 ml with H 2 O. The samples in the autosampler vials
Results
were first analyzed for B[a]P-tetraols and then for G. Levels of B[a]P-tetraols released from mouse lung and liver DNA were expressed as pmol/µmol G.
IC 50 values were determined for inhibition of B[a]P

Fluorometric analysis of B[a]P-tetraols
metabolism by BITC or PEITC in mouse lung or liver microsomes. These data are summarized in Table I . In lung,
The method used in this study is a modification of that described previously 6 or 24 h after treatment with 6.7 µmol BITC or PEITC. This method is similar to that described previously (24) . G from about 2 µg results for lung at 6 h are illustrated in Figure 3A . by 53% and 3-OH-B[a]P by 52%. Small but significant opposing effects were seen on B[a]P-9,10-diol, which was PEITC were generally modest ( Figure 3C Figure 3D ). was observed. PEITC significantly enhanced levels of B[a]P-9,10-diol (by 83%) and B[a]P-7,8-diol (by 139%), whereas its
The effects of various concentrations of isothiocyanates on mouse liver microsomal metabolism of B[a]P-7,8-diol to inhibitory effects on other metabolites persisted.
In liver, 6 h after treatment, the effects of both BITC and mutagenic products was examined using the umu gene response in the chimeric plasmid pSK1002, carried in Salmonella typhimurium TA 1535, as an endpoint. The results, which are standards every 12 h, we could detect any variations in the summarized in Figure 4 , demonstrate that BITC was more analysis conditions using the automated method. effective than PEITC as an inhibitor of mutagenic response in For determination of the effects of isothiocyanates on B[a]Pthis system, presumably resulting from inhibition of BPDE DNA adduct formation, mice were treated with BITC or formation.
PEITC (6.7 µmol) by gavage, then 15 min later with B[a]P The effects of BITC and PEITC on BPDE-DNA adduct (7.9 µmol) by gavage. They were killed at various intervals formation in mouse lung and liver were examined by a after B
[a]P treatment and DNA was isolated and analyzed. fluorometric method (21,23). B[a]P-tetraols were released from
The results of the analyses in lung are summarized in Figure  DNA The AUC in the BITC-B[a]P group was 29.5% less (P ϭ continuous sparging of solvents with high purity He and elution 0.001) than in the B[a]P group (Table II) Table II) . The results were similar to those obtained for solvents with He also resulted in decreasing the limit of total B[a]P-tetraols, with the exception of trans-syn-B[a]Pdetection from 5 fmol (1.3 pg) to 2 fmol (0.6 pg), with a tetraol ( Figure 6G and H), which is the least abundant signal to noise ratio of 2.0.
isomer. In this case, the scatter was greater and no significant A typical chromatogram is shown in Figure 5 . Occasionally, differences were observed among the groups. There were no peaks other than those corresponding to authentic B[a]Psignificant differences between the AUCs in the BITC-B[a]P tetraols were observed, including a shoulder on the trans-antiand PEITC-B[a]P groups for any of the tetraols.
B[a]P-tetraol. Identification of the source of these fluorescent
The results of the adduct analyses in mouse liver are peaks was not pursued; however, they were not observed in illustrated in Figure 7A and B. The results were remarkably DNA from untreated mice. Analysis of ethanol washes of similar to those obtained in lung. Adduct formation in the DNA prior to hydrolysis did not reveal free B[a]P-tetraols; BITC-B[a]P group was consistently inhibited 12-120 h after thus, all B[a]P-tetraols analyzed here were released from B[a]P treatment compared with the group treated with B[a]P adducted DNA by acid hydrolysis.
alone; overall reduction was 35.6% (P ϭ 0.0007; Table II ). In Continual automated HPLC analysis was used in this study, the mice treated with PEITC and B[a]P, adduct formation was as each chromatographic run required 80 min. Internal standard, inhibited only at the 12 and 24 h time points, but the overall B[a]P-triol, was added to each sample to detect and quantify AUC was reduced by 25.1%, which was significantly lower variations in fluorometric analysis. B[a]P-triol was chosen than in the B[a]P treated mice (P ϭ 0.006). As in lung, data because of its similar structure to the B[a]P-tetraols, its for the individual tetraols generally resembled that for the convenient retention time, and the similar sensitivity of its total, except in the case of trans-syn-B[a]P-tetraol (Table II) . fluorescence to oxygen quenching. Variations in the area of There were no significant differences between the BITC-B[a]P the internal standard were Ͻ5%. With the addition of the internal standard to each sample, and analysis of B[a]P-tetraol and PEITC-B[a]P groups. (Table I ). In lung microsomes obtained P450 enzymes. Isothiocyanates are known to be effective from mice treated with BITC, inhibition of B[a]P-7,8-diol inhibitors of cytochromes P450 (5,6,27). Treatment of A/J formation was observed 6 h after treatment, although this mice with BITC inhibits lung microsomal ethoxyresorufin-Oeffect disappeared 24 h after ( Figure 3A and B) . In addition, dealkylase activity and pentoxyresorufin-O-dealkylase activity, BITC inhibited the formation of mutagens from B[a]P-7,8-indicating inhibition of cytochromes P450 1A and 2B1, respectdiol (Figure 4) . The results of the BPDE-DNA adduct studies ively (28). BITC is also a mechanism-based inactivator of are consistent with these findings. In mouse lung, BITC cytochrome P450 2E1 (29) . As B[a]P metabolism is known inhibited adduct formation 12-120 h after treatment ( Figure  6A ). An exception to this consistent pattern was the in vitro to be catalyzed in part by cytochromes P450 1A1 and 1A2 (11-14), and there is evidence for the presence of these relatively ineffective inhibitor (Figure 4 ). These observations are consistent with the smaller inhibition of BPDE-DNA enzymes in mouse liver and lung (30, 31) , it seems probable that inhibition of cytochrome P450 1A enzymes by BITC adduct formation in lung and liver by PEITC compared with BITC. Whereas BITC inhibited BPDE-DNA adduct formation partially explains the observed inhibition of B[a]P metabolism. Inhibition of other cytochromes P450, such as P450 1B1, may by 29.5 and 35.6% in lung and liver, respectively, the corresponding figures for PEITC were 19.0 and 25.1%. While the also be involved (32) . BITC is also known to induce phase II enzymes (33) . Pre-treatment of mice with BITC results in AUC data for PEITC and BITC were not significantly different, they do indicate a less pronounced inhibitory effect of PEITC induction of glutathione S-transferases in liver, lung and other tissues (33) (34) (35) . Enhancing effects on the activity of on BPDE-DNA adduct formation. Nevertheless, based on these data, we might have expected inhibition of B[a]P-induced NAD(P)H:(quinone acceptor)oxidoreductase have also been observed (33) . Since glutathione S-transferases are involved lung tumorigenesis by PEITC, but this was not observed (8,9). It is possible that there are larger differences between inhibition in the detoxification of BPDE as well as other epoxide metabolites of B[a]P (11-14), this could have played a role in of BPDE-DNA adduct formation by BITC and PEITC in particular lung cell types, which were not examined here. It the decreased levels of BPDE-DNA adducts observed here.
PEITC also inhibited B[a]P metabolism in vitro, with IC 50 is also possible that DNA adducts other than those formed from BPDE are important in A/J mouse lung tumorigenesis. values similar to, or lower than, those of BITC (Table I) . In lung microsomes isolated from mice treated with PEITC, As we did not use radiolabelled B[a]P in this study, we would not have detected other DNA adducts. In previous studies, inhibition of metabolism was similar to that observed with BITC, 6 h after treatment ( Figure 3A) . However, a major we and others have observed early eluting radioactivity in enzymatic hydrolysates of DNA from the lungs and livers of difference between PEITC and BITC was seen 24 h after treatment, when levels of B[a]P-7,8-diol and B[a]P-9,10-diol mice treated with [ 3 H]B[a]P (36, 37) . This radioactivity has not been characterized. Moreover, 'depurinating-DNA adducts' were substantially increased by PEITC, whereas they remained unaffected by BITC ( Figure 3B) aspects should be investigated in future studies. 
